Back to top
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com Most Recent Articles
3 Momentum Anomaly Stocks to Buy as Tech Rout Spooks Markets
Analyst Blog
by Supriyo Bose
MU, LRCX and KLAC stand out as momentum stocks resurface, even as a tech rout and crypto slump rattle broader U.S. equity markets.
MUPositive Net Change KLACPositive Net Change LRCXPositive Net Change
artificial-intelligence semiconductor tech-stocks
Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates
Tale of the Tape
by Zacks Equity Research
Canopy Growth (CGC) delivered earnings and revenue surprises of -200.30% and +5.70%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
CGCNegative Net Change PRGONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Philip Morris (PM) Q4 Earnings Top Estimates
Tale of the Tape
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of +2.04% and -0.63%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
PMPositive Net Change TPBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Grab 3 Stocks That Announced Dividend Hikes Amid Market Volatility
Analyst Blog
by Ritujay Ghosh
NYT, YUMC and ESQ announce dividend hikes as volatility rises, offering steady income options amid inflation, rates and market swings.
NYTPositive Net Change YUMCPositive Net Change ESQNegative Net Change
consumer-staples finance restaurants
Can FuelCell Energy Improve ROI at Fossil Power Plants?
Analyst Blog
by Nilanjan Choudhury
FCEL pitches carbon capture that adds power, cuts compliance costs, and extends coal and gas plant life with modular, scalable systems.
CVXNegative Net Change OXYNegative Net Change FCELNegative Net Change
alt-energy energy oil-energy
Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
Analyst Blog
by Zacks Equity Research
INCY heads into Q4 earnings with strong Jakafi sales, rising royalties and multiple new launches contributing to revenues, setting the stage for a potential upside surprise.
NVSPositive Net Change LLYNegative Net Change INCYPositive Net Change MRNANegative Net Change
biotechnology biotechs earnings medical oncology-screening pharmaceuticals
Ubiquiti Inc. (UI) Tops Q2 Earnings and Revenue Estimates
Tale of the Tape
by Zacks Equity Research
Ubiquiti (UI) delivered earnings and revenue surprises of +38.08% and +13.18%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
UIPositive Net Change ASTSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release?
Analyst Blog
by Sundeep Ganoria
Aurora Cannabis beat Q3 earnings and sales estimates as medical cannabis momentum drove growth, but persistent consumer weakness pressured the stock outlook.
CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change
marijuana medical pot-stocks
Piper Sandler Companies (PIPR) Q4 Earnings and Revenues Beat Estimates
Tale of the Tape
by Zacks Equity Research
Piper Sandler Companies (PIPR) delivered earnings and revenue surprises of +45.76% and +23.21%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
PIPRNegative Net Change BGCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates
Tale of the Tape
by Zacks Equity Research
Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +9.43% and -67.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ROIVNegative Net Change TCRXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank